A striking difference between the BCP-ALL subtypes is that the patients carrying the recurrent fusion genes ETV6-RUNX1, BCR-ABL or TCF3-PBX1 harbored exceptionally few mutations in known driver genes compared to the other BCP-ALL patients. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.